ŞANLIOĞLU, A. D. Et Al. 2008. Pancreatic ductal adenocarcinoma (PDAC) patients reveal elevated TRAIL Death Receptor-4 (DR4) and decoy receptor-2 (DcR2) expression correlated with significant cell death. XVIth Annual Congress of the European Society of Gene and Cell Therapy , (Brüksel, Belgium), 1104.

ŞANLIOĞLU, A. D., DİRİCE, E., ELPEK, G. Ö., KORCUM, A. F., ÖZDOĞAN, M., SÜLEYMANLAR, İ., ... BALCI, M. K.(2008). Pancreatic ductal adenocarcinoma (PDAC) patients reveal elevated TRAIL Death Receptor-4 (DR4) and decoy receptor-2 (DcR2) expression correlated with significant cell death . XVIth Annual Congress of the European Society of Gene and Cell Therapy (pp.1104). Brüksel, Belgium

ŞANLIOĞLU, AHTER Et Al. "Pancreatic ductal adenocarcinoma (PDAC) patients reveal elevated TRAIL Death Receptor-4 (DR4) and decoy receptor-2 (DcR2) expression correlated with significant cell death," XVIth Annual Congress of the European Society of Gene and Cell Therapy, Brüksel, Belgium, 2008

ŞANLIOĞLU, AHTER D. Et Al. "Pancreatic ductal adenocarcinoma (PDAC) patients reveal elevated TRAIL Death Receptor-4 (DR4) and decoy receptor-2 (DcR2) expression correlated with significant cell death." XVIth Annual Congress of the European Society of Gene and Cell Therapy , Brüksel, Belgium, pp.1104, 2008

ŞANLIOĞLU, A. D. Et Al. (2008) . "Pancreatic ductal adenocarcinoma (PDAC) patients reveal elevated TRAIL Death Receptor-4 (DR4) and decoy receptor-2 (DcR2) expression correlated with significant cell death." XVIth Annual Congress of the European Society of Gene and Cell Therapy , Brüksel, Belgium, p.1104.

@conferencepaper{conferencepaper, author={AHTER DİLŞAD ŞANLIOĞLU Et Al. }, title={Pancreatic ductal adenocarcinoma (PDAC) patients reveal elevated TRAIL Death Receptor-4 (DR4) and decoy receptor-2 (DcR2) expression correlated with significant cell death}, congress name={XVIth Annual Congress of the European Society of Gene and Cell Therapy}, city={Brüksel}, country={Belgium}, year={2008}, pages={1104} }